Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Mittman

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 13, 1999
Iron replacement in rHuEPO-treated dialysis patients: DOQI and beyondN Mittman
Seminars in Nephrology|May 1, 1996
Dyslipidemia in renal diseaseN Mittman, M M Avram
Seminars in Nephrology|May 1, 1994
Malnutrition in uremiaM M Avram, N Mittman
Prostaglandins|September 1, 1985
Salicylate nephropathy in the Gunn rat: potential role of prostaglandinsN Mittman, R Janis, D Schlondorff
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 1, 1985
The changing spectrum of heroin-associated nephropathyA Dubrow, N Mittman, V Ghali, et al.
Journal of Clinical Hypertension|March 1, 1986
Combination therapy with enalapril and hydrochlorothiazide: optimal dose, renin response, and prostaglandin excretionN Mittman, A Dubrow, M Westerman, et al.
Reviews of Infectious Diseases|January 1, 1983
Infectious diseases of the thyroid glandS A Berger, J Zonszein, P Villamena, et al.
Journal of the American College of Surgeons|March 5, 1999
Survival among chronic renal failure patients requiring major abdominal surgeryL A Newman, N Mittman, Z Hunt, et al.
Journal of Clinical Hypertension|December 1, 1985
Safety and efficacy of guanabenz in hypertensive patients with moderate renal insufficiencyA Dubrow, N Mittman, P DeCola, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1984
Safety and efficacy of epoprostenol (PGI2) versus heparin (H) in hemodialysis (HD)A Dubrow, W Flamenbaum, N Mittman, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 13, 1999
Iron replacement in rHuEPO-treated dialysis patients: DOQI and beyondN Mittman
Seminars in Nephrology|May 1, 1996
Dyslipidemia in renal diseaseN Mittman, M M Avram
Seminars in Nephrology|May 1, 1994
Malnutrition in uremiaM M Avram, N Mittman
Prostaglandins|September 1, 1985
Salicylate nephropathy in the Gunn rat: potential role of prostaglandinsN Mittman, R Janis, D Schlondorff
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 1, 1985
The changing spectrum of heroin-associated nephropathyA Dubrow, N Mittman, V Ghali, et al.
Journal of Clinical Hypertension|March 1, 1986
Combination therapy with enalapril and hydrochlorothiazide: optimal dose, renin response, and prostaglandin excretionN Mittman, A Dubrow, M Westerman, et al.
Reviews of Infectious Diseases|January 1, 1983
Infectious diseases of the thyroid glandS A Berger, J Zonszein, P Villamena, et al.
Journal of the American College of Surgeons|March 5, 1999
Survival among chronic renal failure patients requiring major abdominal surgeryL A Newman, N Mittman, Z Hunt, et al.
Journal of Clinical Hypertension|December 1, 1985
Safety and efficacy of guanabenz in hypertensive patients with moderate renal insufficiencyA Dubrow, N Mittman, P DeCola, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1984
Safety and efficacy of epoprostenol (PGI2) versus heparin (H) in hemodialysis (HD)A Dubrow, W Flamenbaum, N Mittman, et al.
Pageof 3